Study on the antituberculous activity of tuberactinomycin, a new antimicrobial drug.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D004352:Drug Resistance, Microbial; D006168:Guinea Pigs; D007612:Kanamycin / Q000494:pharmacology; D051379:Mice; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification; D014376:Tuberculosis / Q000188:drug therapy; D014756:Viomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D007612:Kanamycin; D014756:Viomycin